Navigation Links
United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
Date:10/27/2011

st quarter of 2011. The results of Medicomp have been reported within discontinued operations on our consolidated statements of operations below.  For further information, refer to our Quarterly Report on Form 10-Q for the three months ended September 30, 2011, Note 14 – Sale of Medicomp, Inc. Earnings Before Non-Cash ChargesEarnings before non-cash charges is defined as net income, adjusted for the following non-cash charges, as applicable: (1) interest; (2) income taxes; (3) license fees; (4) depreciation and amortization; (5) impairment charges; and (6) share-based compensation (stock option and share tracking award expense).

A reconciliation of net income to earnings before non-cash charges is presented below (in thousands, except per share data):Three Months Ended September 30,20112010Net income, as reported

$

84,398$

39,736Adjust for non-cash charges:Interest expense

5,4164,809Income tax expense

17,64118,217License fees

41,332(1)

—Depreciation and amortization

4,9915,028Impairment charges

(5,366)(2)

—Share-based compensation

(47,609)31,526Earnings before non-cash charges

$

100,803$

99,316Earnings before non-cash charges per share:Basic

$

1.73$

1.76Diluted

$

1.65$

1.65Weighted average number of common shares outstanding:  Basic

58,32156,536  Diluted

61,21060,216(1) Includes the non-cash portion of the charge to research and development expense for the three months ended September 30, 2011, incurred in connection with our July 2011 amended license agreement with Toray Industries, Inc.(2) Consists of a non-cash gain recognized in connection with the sale of Medicomp due to our ability to utilize certain of Medicomp's deferred tax assets for our 2010 tax return filed in September 2011.  Conference CallWe will host a half-hour teleconference on Thursda
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
2. United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011
3. United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program
4. United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program
5. Full-day "United Nations" Online Investor Conference: October 6th at RetailInvestorConferences.com
6. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
7. FDA Advisory Panel Unanimously Recommends Approval of EXCOR(R) Pediatric Ventricular Assist Device for Use in the United States
8. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
9. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
10. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
11. United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 Savoury Systems ... has appointed Dale Braddy to Southeastern USA Sales Broker. ... its sales muscle in the Southeast. , ... ingredient brokerage and supplier to food processors and industrial ... years in the food industry and has over 25 ...
(Date:5/21/2013)... According to a new market ... "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, ... Share, Growth, Trends and Forecast, 2012 - 2018," the market was valued ... to grow at a CAGR of 10.1% from 2012 ... 4.7 billion in 2018. Browse the full ...
(Date:5/21/2013)... 2013 Emerson Resources Inc. , ... Charles Signorino, the Company’s Chief Executive Officer and Chairman ... 32 years of service. As part of Emerson Resources’ ... has been named as Dr. Signorino’s successor. , ... industry, having made a significant contribution to the field ...
(Date:5/21/2013)... 21, 2013  Personal Genome Diagnostics Inc. (PGDx), ... methodologies and expertise in genomic analysis of defined ... collaboration with Blueprint Medicines.  PGDx is an innovator ... alterations in tumors, and Blueprint Medicines is an ... a genetically defined patient population. "This ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3
... new facility, based in Los Angeles, California is anticipated ... ability to supply its new, generation of ... ANGELES, Oct. 6 Today, Grifols SA (Grifols), a,global ... a new,92,000 square foot, intravenous immune globulin (IVIG) production ...
... ANTWERP and AALST , Belgium, AHMEDABAD, India ... Research, genae associates,Cardiovascular Center Aalst and J.B. ... a Core Laboratories joint venture, called imaeon., ... performance of medical images,analysis for clinical research ...
... deCODE genetics,(Nasdaq: DCGN ) today announced that ... Nasdaq Stock Market stating that for 10 consecutive trading,days ... below $50 million,the minimum level required for continued listing ... Marketplace Rule 4450(b)(1)(A). The notice,further stated that deCODE also ...
Cached Biology Technology:Grifols Breaks Ground on New IVIG Facility 2Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm 2deCODE Receives Nasdaq Deficiency Notice Relating to Market Value 2deCODE Receives Nasdaq Deficiency Notice Relating to Market Value 3
(Date:5/21/2013)... When infections occur in the body, stem cells ... multiplying and differentiating into mature immune cells that ... inflammation can deplete these cell populations, potentially leading ... as cancer. Now, a team of researchers led ... (Caltech) has found that, in mouse models, the ...
(Date:5/21/2013)... phosphatidylserine is a natural food supplement produced from ... and slow memory loss, it,s a popular treatment ... team headed by Prof. Gil Ast and Dr. ... Human Molecular Genetics have discovered that ... involved in degenerative brain disorders, including Parkinson,s disease ...
(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center Congress ... , Why? An annual meeting ... developments, manufacturing and installation, drawing on leading experiences from ... edition from a record of more than 900 abstracts ... plenary and oral presentations, more than 460 visual presentation, ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4
... people in the United States alone suffer from rheumatoid arthritis ... in the joints. Now researchers at Brigham and Women,s Hospital ... for treating these diseases and others. Among its advantages, ... an affected joint, and could dispense that medicine on demand ...
... copepods rule the world, at least when it comes ... organisms in the seas, copepods are an important link ... To understand and predict how copepods respond to environmental ... new copepods are born, but how many are dying, ...
... Lockheed Martin (NYSE: LMT ) has been ... of the Year" by Frost and Sullivan, recognizing the ... high levels of customer value. "Lockheed ... that play an important role our customer,s law enforcement ...
Cached Biology News:Injectable gel could spell relief for arthritis sufferers 2Injectable gel could spell relief for arthritis sufferers 3Death -- not just life -- important link in marine ecosystems 2Lockheed Martin Named Biometrics "Company of the Year" by Frost and Sullivan 2
... FACSVantageTM SE flow cytometry system is the ... For over 25 years, BD cell sorters ... found in leading university, pharmaceutical, and biotechnology ... meet the research demands of today, we ...
Reacti-Bind DNA Coating Solution...
... The versatile ST-195 allows real-time observations ... conditions. This instrument has 64 different strain ... CO2 incubator. The thin silicon strain chamber ... inverted microscopes and fluorescence microscopy. ST-195 can ...
... Control and regulate cell stretching or compression ... microscope stage. Computer controlled so you can ... the strain to produce 64 unique strain ... then the ST-150. Both models are compatible ...
Biology Products: